Income Statement
Balance Sheet
Cash Flow
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cost Of Revenue | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Gross Profit | -604.00 | -580.00 | -575.00 | -569.00 | -591.00 |
| Selling General And Administration | 144,604 | 176,444 | 160,654 | 69,036 | 147,302 |
| General And Administrative Expense | 144,604 | 176,444 | 160,654 | 69,036 | 147,302 |
| Other Operating Expenses | 63,489 | 464,437 | 434,258 | 476,195 | 400,853 |
| Operating Expense | 208,093 | 640,881 | 594,912 | 545,231 | 548,155 |
| Operating Income | -208,697 | -641,461 | -595,487 | -545,800 | -548,746 |
| EBIT | -208,697 | -641,461 | -595,487 | -545,800 | -548,746 |
| Other Income Expense | 1,041 | -5,994 | -6,555 | 8,034 | 11,867 |
| Other Non Operating Income Expenses | 2,252 | -- | -- | 0.00 | 2,250 |
| Special Income Charges | -- | -- | -- | -1,168 | 0.00 |
| Gain On Sale Of Security | -1,211 | -5,994 | -6,555 | 9,202 | 9,617 |
| Pretax Income | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Tax Effect Of Unusual Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income From Continuing And Discontinued Operation | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Net Income From Continuing Operation Net Minority Interest | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Net Income Including Noncontrolling Interests | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Net Income Common Stockholders | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Net Income | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| EBITDA | -208,093 | -640,881 | -594,912 | -545,231 | -548,155 |
| Normalized EBITDA | -206,882 | -634,887 | -588,357 | -553,265 | -557,772 |
| Reconciled Depreciation | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Basic EPS | 0.00 | -0.01 | -0.01 | -- | -0.01 |
| Diluted EPS | 0.00 | -0.01 | -0.01 | -- | -0.01 |
| Basic Average Shares | 107.9M | 107.9M | 107.9M | -- | 67.3M |
| Diluted Average Shares | 107.9M | 107.9M | 107.9M | -- | 67.3M |
| Total Unusual Items | -1,211 | -5,994 | -6,555 | 8,034 | 9,617 |
| Total Unusual Items Excluding Goodwill | -1,211 | -5,994 | -6,555 | 8,034 | 9,617 |
| Tax Rate For Calcs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Income | -206,445 | -641,461 | -595,487 | -545,800 | -546,496 |
| Diluted NI Availto Com Stockholders | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Gain On Sale Of Ppe | -- | -- | -- | -1,168 | 0.00 |
| Insurance And Claims | 3,940 | 3,941 | 7,054 | 6,413 | 6,412 |
| Net Income Continuous Operations | -207,656 | -647,455 | -602,042 | -537,766 | -536,879 |
| Net Income Discontinuous Operations | -- | -- | -- | 0.00 | 0.00 |
| Other Gand A | 71,256 | 134,811 | 124,079 | 79,940 | 123,659 |
| Reconciled Cost Of Revenue | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Rent And Landing Fees | 5,393 | 5,364 | 5,364 | 5,335 | 5,316 |
| Rent Expense Supplemental | 5,393 | 5,364 | 5,364 | 5,335 | 5,316 |
| Salaries And Wages | 64,015 | 32,328 | 24,157 | -22,652 | 11,915 |
| Total Expenses | 208,697 | 641,461 | 595,487 | 545,800 | 548,746 |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Cash And Cash Equivalents | 714,595 | 937,611 | 1.6M | 2.3M | 727,037 |
| Cash Cash Equivalents And Short Term Investments | 714,595 | 937,611 | 1.6M | 2.3M | 727,037 |
| Cash Financial | -- | -- | -- | 2.3M | 727,037 |
| Accounts Receivable | 7,868 | 10,336 | 6,172 | 8,283 | 5,749 |
| Receivables | 7,868 | 10,336 | 6,172 | 153,283 | 5,749 |
| Other Current Assets | 16,022 | 27,321 | 23,677 | 5,742 | 13,000 |
| Current Assets | 738,485 | 975,268 | 1.7M | 2.4M | 745,786 |
| Gross PPE | 8,276 | 7,901 | 7,675 | 7,554 | 8,672 |
| Accumulated Depreciation | -7,129 | -6,214 | -5,460 | -4,692 | -4,205 |
| Net PPE | 1,147 | 1,687 | 2,215 | 2,862 | 4,467 |
| Total Non Current Assets | 1.0M | 962,403 | 869,913 | 803,631 | 744,707 |
| Total Assets | 1.8M | 1.9M | 2.5M | 3.2M | 1.5M |
| Accounts Payable | 258,234 | 345,414 | 381,393 | 225,309 | 188,383 |
| Payables | 261,117 | 350,124 | 384,728 | 225,309 | 191,718 |
| Payables And Accrued Expenses | 261,117 | 350,124 | 384,728 | 494,525 | 191,718 |
| Current Accrued Expenses | -- | -- | -- | 269,216 | -- |
| Current Liabilities | 261,117 | 350,124 | 384,728 | 494,525 | 191,718 |
| Total Non Current Liabilities Net Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Liabilities Net Minority Interest | 261,117 | 350,124 | 384,728 | 494,525 | 191,718 |
| Common Stock | 28.1M | 28.1M | 28.1M | 28.1M | 26.2M |
| Capital Stock | 28.1M | 28.1M | 28.1M | 28.1M | 26.2M |
| Additional Paid In Capital | 4.5M | 4.4M | 4.4M | 4.4M | 4.4M |
| Retained Earnings | -31.3M | -31.1M | -30.4M | -29.8M | -29.3M |
| Gains Losses Not Affecting Retained Earnings | 124,987 | 68,112 | 29,130 | 12,001 | 7,279 |
| Other Equity Adjustments | 124,987 | 68,112 | 29,130 | 12,001 | 7,279 |
| Common Stock Equity | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Stockholders Equity | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Total Equity Gross Minority Interest | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Total Capitalization | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Net Tangible Assets | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Tangible Book Value | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Working Capital | 477,368 | 625,144 | 1.3M | 1.9M | 554,068 |
| Invested Capital | 1.5M | 1.6M | 2.2M | 2.7M | 1.3M |
| Share Issued | 107.9M | 107.9M | 107.9M | 107.9M | 67.3M |
| Ordinary Shares Number | 107.9M | 107.9M | 107.9M | 107.9M | 67.3M |
| Dueto Related Parties Current | 2,883 | 4,710 | 3,335 | -- | 3,335 |
| Machinery Furniture Equipment | 8,276 | 7,901 | 7,675 | 7,554 | 8,672 |
| Non Current Accounts Receivable | 1.0M | 960,716 | 867,698 | 800,769 | 740,240 |
| Other Receivables | -- | -- | -- | 145,000 | -- |
| Line Item | Q3 2025Sep 30, 2025 | Q2 2025Jun 30, 2025 | Q1 2025Mar 31, 2025 | Q4 2024Dec 31, 2024 | Q3 2024Sep 30, 2024 |
|---|---|---|---|---|---|
| Operating Cash Flow | -239,088 | -724,929 | -614,217 | -296,320 | -562,681 |
| Cash Flow From Continuing Operating Activities | -239,088 | -724,929 | -614,217 | -296,320 | -562,681 |
| Depreciation And Amortization | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Depreciation Amortization Depletion | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Stock Based Compensation | 64,015 | 32,328 | 24,157 | -22,652 | 11,915 |
| Change In Working Capital | -96,051 | -110,382 | -36,907 | 262,361 | -34,074 |
| Changes In Account Receivables | 2,670 | -4,043 | 2,176 | -2,499 | 286.00 |
| Change In Receivables | -14,250 | -70,111 | 93,159 | -57,917 | -55,691 |
| Change In Payables And Accrued Expense | -93,242 | -36,712 | -112,177 | 312,995 | 14,371 |
| Purchase Of PPE | -- | -- | -- | 0.00 | 0.00 |
| Net PPE Purchase And Sale | -- | -- | -- | 0.00 | 0.00 |
| Sale Of Business | -- | -- | -- | 0.00 | 0.00 |
| Sale Of Investment | -- | -- | -- | 0.00 | 0.00 |
| Net Investment Purchase And Sale | -- | -- | -- | 0.00 | 0.00 |
| Investing Cash Flow | -- | -- | -- | 0.00 | 0.00 |
| Cash Flow From Continuing Investing Activities | -- | -- | -- | 0.00 | 0.00 |
| Issuance Of Capital Stock | -- | -- | -- | 1.9M | 0.00 |
| Net Common Stock Issuance | -- | -- | -- | 1.9M | 0.00 |
| Financing Cash Flow | -- | -- | -- | 1.8M | 0.00 |
| Cash Flow From Continuing Financing Activities | -- | -- | -- | 1.8M | 0.00 |
| Effect Of Exchange Rate Changes | 16,072 | 13,882 | 6,559 | -10,770 | 4,371 |
| Changes In Cash | -239,088 | -724,929 | -614,217 | 1.5M | -562,681 |
| Beginning Cash Position | 937,611 | 1.6M | 2.3M | 727,037 | 1.3M |
| End Cash Position | 714,595 | 937,611 | 1.6M | 2.3M | 727,037 |
| Free Cash Flow | -239,088 | -724,929 | -614,217 | -296,320 | -562,681 |
| Cash From Discontinued Operating Activities | -- | -- | -- | 0.00 | 0.00 |
| Change In Prepaid Assets | 11,441 | -3,559 | -17,889 | 7,283 | 7,246 |
| Common Stock Issuance | -- | -- | -- | 1.9M | 0.00 |
| Depreciation | 604.00 | 580.00 | 575.00 | 569.00 | 591.00 |
| Gain Loss On Sale Of PPE | -- | -- | -- | 1,168 | 0.00 |
| Net Business Purchase And Sale | -- | -- | -- | 0.00 | 0.00 |
| Net Foreign Currency Exchange Gain Loss | -- | -- | -- | -- | 0.00 |
| Net Income From Continuing Operations | -207,656 | -647,455 | -602,042 | -537,766 | -541,113 |